Study shows wide variation in head and neck cancer care

July 29, 2013

Just three in every hundred head and neck cancer patients in England receive the ideal standard of care, according to a new study.

The National Head and Neck Cancer Audit found wide variations in care, with just 3.1 per cent of patients receiving every element of care deemed important by experts.

Sara Osborne, of policy at Cancer Research UK, said it was "disappointing" to see such variation in care for patients with head and neck cancers.

But the figures also show there has been an improvement in among patients over the last two years, despite variations in care.

The Ideal Patient Pathway contains seven elements of "holistic and integrated care" such as nutritional, speech and language and dental assessments and chest scans or x-rays before surgery.

It also involves people's disease being discussed by a multi-disciplinary team including specialist surgeons, , speech therapists and nursing staff.

Researchers examined data submitted by all head and neck cancer teams in England and Wales, relating to the care of 8,100 patients between November 2011 and October 2012.

They found that the largest group of patients (24.7 per cent) received three elements of the Ideal Patient Pathway, with some aspects delivered more consistently than others.

For example, 96.4 per cent of surgical head and neck had their case discussed by a multi-disciplinary team, but just 18.8 per cent had an assessment with a speech and language therapist before surgery.

The findings are published in the National Head and Neck Cancer Audit eighth Annual Report 2012, commissioned by the Healthcare Quality Improvement Partnership.

According to the data, there has been an improvement in survival rates among head and neck cancer patients over the last two years. The figures show that the number of patients who survived a year from their diagnosis rose from 84.4 per cent in 2010 to 87.5 per cent in 2012.

The authors cautioned against attributing this solely to improvements in the delivery of patient care, but said it is an encouraging trend that should be explored in more detail.

The audit's lead clinician Mr Richard Wight said: "We are delighted to report again the involvement of the head and community in actively contributing to audit, which forms a key part in promoting better care.

"The new focus on the Ideal Patient Pathway has been encouraged by patient representatives. This analysis supports continuing improvement and provides assurance to commissioners of head and neck cancer care."

Dr Emma King, Cancer Research UK head and neck cancer surgeon, said: "We all must strive towards every patient receiving the 'ideal pathway'. This data will help us identify problem areas that need to be addressed in order to achieve this."

Cancer Research UK's Sara Osborne added: "It's now up to the new Strategic Clinical Networks to provide clinical support to address any variation in care for all head and neck cancer patients wherever they are in the country."

Explore further: Liposuction for the management of submental lymphedema in the head and neck cancer patient

Related Stories

Liposuction for the management of submental lymphedema in the head and neck cancer patient

June 12, 2012
Liposuction is a novel and minimally invasive procedure for treating persistent submental lymphedema in patients with previous head and neck cancer, according to an article published in the June 2012 issue of Otolaryngology–Head ...

Racial disparity in head and neck cancer outcomes

April 19, 2013
(HealthDay)—Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival, according to a study published online April 18 in JAMA Otolaryngology-Head ...

FATE results prove to be useful in end-of-life care

May 2, 2011
Though there have been significant improvements in the treatment of head and neck cancer, there is still a lack of data on the experience of end of life care for head and neck cancer patients, according to a new study published ...

The effect of treating institution on outcomes in head and neck cancer

December 7, 2012
Patients with head and neck cancer receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a study in the December 2012 issue of Otolaryngology–Head ...

Standard treatments for head and neck cancer less effective in HIV-positive patients

January 26, 2012
Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary ...

Study shows how the Nanog protein promotes growth of head and neck cancer

June 18, 2013
A study led by researchers at The Ohio State University Comprehensive Cancer Center-– Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) has identified a biochemical pathway in cancer ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.